{"title":"Cardiovascular Disease Among International Travellers","authors":"D. Mensah, P. Simkhada","doi":"10.34172/ijtmgh.2021.18","DOIUrl":null,"url":null,"abstract":"Introduction: Cardiovascular disease (CVD) is the leading cause of death among international travellers. This study aims to estimate the proportion of travellers diagnosed with CVD during international travel. Methods: A narrative synthesis of peer-reviewed literature was conducted on CVD among international travellers. Healthcare databases and sources of grey literature were searched using pre-defined criteria between February and June 2019. Two reviewers screened all the identified studies against protocol and extracted data using a piloted form. Results: Eight studies were eligible for final analysis. Four studies evaluated data from GeoSentinel Clinic databases. The number of study participants varied across studies from a minimum of 24 to a maximum of 63076. Between 0.1% and 14% of international travellers were reported or diagnosed with CVD while travelling abroad. CVD was common in male travellers as compared with female travellers. There was a lack of information on pre-existing morbidity, smoking status, obesity in all included studies. Conclusion: This review provides a first-time estimate of the proportion of international travellers with CVD while travelling overseas. Hence, preventive measures to minimize CVD risk such as sufficient exercises during long-distance flights, progressive acclimatization to altitude, wearing a face mask in polluted areas, maintaining a healthy lifestyle, and nutrition during travelling should be considered. CVD should be an important part of pre-travel health advice.","PeriodicalId":32539,"journal":{"name":"International Journal of Travel Medicine and Global Health","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Travel Medicine and Global Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/ijtmgh.2021.18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Introduction: Cardiovascular disease (CVD) is the leading cause of death among international travellers. This study aims to estimate the proportion of travellers diagnosed with CVD during international travel. Methods: A narrative synthesis of peer-reviewed literature was conducted on CVD among international travellers. Healthcare databases and sources of grey literature were searched using pre-defined criteria between February and June 2019. Two reviewers screened all the identified studies against protocol and extracted data using a piloted form. Results: Eight studies were eligible for final analysis. Four studies evaluated data from GeoSentinel Clinic databases. The number of study participants varied across studies from a minimum of 24 to a maximum of 63076. Between 0.1% and 14% of international travellers were reported or diagnosed with CVD while travelling abroad. CVD was common in male travellers as compared with female travellers. There was a lack of information on pre-existing morbidity, smoking status, obesity in all included studies. Conclusion: This review provides a first-time estimate of the proportion of international travellers with CVD while travelling overseas. Hence, preventive measures to minimize CVD risk such as sufficient exercises during long-distance flights, progressive acclimatization to altitude, wearing a face mask in polluted areas, maintaining a healthy lifestyle, and nutrition during travelling should be considered. CVD should be an important part of pre-travel health advice.